Statistics for Eton Pharmaceuticals (id:6854 ETON)

Valuation metrics

Market cap

290.14M

Enterprise value

261.05M

Trailing P/E (ttm)

124.00

Forward P/E

21.19

PEG ratio

21.19

Price/Sales (ttm)

9.25

Price/Book (mrq)

18.65

Enterprise Value/Revenue

8.32

Enterprise Value/EBITDA

-49.12

Overview

Shares outstanding

25.84M

Float

21.69M

Shares short

191.94K

% Held by insiders

0.05%

% Held by institutions

0.33%

Average volume (10 days)

366.06K

Average volume (90 days)

Price summary

52-Week low

3.03

52-Week high

11.44

52-Week change

66.54%

Beta

1.26

50-Day moving average

7.85

200-Day moving average

4.82

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-21.31%

Operating margin

-32.34%

Operational effectiveness

Return on assets

-12.50%

Return on equity

-44.30%

Income statement

Revenue (ttm)

1.22

Revenue per share (ttm)

1.22

Quarterly revenue growth (yoy)

Gross profit (ttm)

21.06M

EBITDA

-5,314,000.00

Net income to common (ttm)

-6,687,000.00

Diluted EPS (ttm)

-0.21

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

17.69M

Total cash per share (mrq)

0.68

Total debt (mrq)

4.88M

Total Debt/Equity (mrq)

36.23

Current ratio (mrq)

139.60%

Book value per share (mrq)

0.60

Cash flow

Cash flow statement

42.00K

Levered free cash flow (LFCF)

-380,250.00